To improve the performance of our website, show the most relevant news products and targeted advertising, we collect technical impersonal information about you, including through the tools of our partners. You can find a detailed description of how we use your data in our Privacy Policy. For a detailed description of the technologies, please see the Cookie and Automatic Logging Policy.
By clicking on the Accept & Close button, you provide your explicit consent to the processing of your data to achieve the above goal.
You can withdraw your consent using the method specified in the Privacy Policy.
Accept & Close
Sputnik International
2. Northern Ireland
The Taoiseach can be more meaty in enlisting the help of the new administration on the overall defence of the Good Friday Agreement, now threatened by proxy because of the row over the Northern Ireland protocol.
Here Mr Martin’s key input will be on answering questions from a well-briefed president who really does want to help. Ireland is already receiving solid support from the EU, which has launched legal action over the UK’s second breach of a binding international treaty it signed up to itself, through London’s arbitrary extension of a transition period on checks on goods coming into Northern Ireland. We could do with a squeeze also coming from the other side of the Atlantic.
Hoth Therapeutics Partners with University of Cincinnati to Perform Critical Studies for Streamlined Development of Novel Antibiotic HT-006 prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
New Phase 1 study evaluates prime/boost HIV-1 vaccine formulated with combinations of adjuvants
A new Phase 1 vaccine study began today that will evaluate experimental prime/boost HIV-1 vaccine regimens formulated with combinations of different adjuvants, including one from the Army Liposome Formulation (ALF) family of adjuvants developed by scientists with the U.S. Military HIV Research Program (MHRP) at the Walter Reed Army Institute of Research.
An adjuvant is a component of a vaccine that can help make it more effective by improving the immune response or causing the immune response to last longer. The goal of the new trial, RV460, is to evaluate whether an adjuvant can improve immune response to the antigens in the candidate vaccines. It will also help characterize the differences between the adjuvants and the role of adjuvants in priming versus boosting.
Activists Fueling Concerns About COVID Vaccine Safety webmd.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from webmd.com Daily Mail and Mail on Sunday newspapers.